Inventor
HEER JAG PAUL
GB28 patents
⚠️ This page may combine multiple inventors who share the name “HEER JAG PAUL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UCB Biopharma SRL
10 patentsUS10906919B2Feb 2, 2021
Fused pentacyclic imidazole derivatives
UCB Biopharma SRL2 citations70
US11912721B2Feb 27, 2024
Fused pentacyclic imidazole derivatives
UCB Biopharma SRL0 citations60
US10953019B2Mar 23, 2021
Fused pentacyclic imidazole derivatives as modulators of TNF activity
UCB Biopharma SRL0 citations51
US10669263B2Jun 2, 2020
Substituted benzimidazole derivative as a modulator of TNF activity
UCB Biopharma SRL0 citations51
US12410161B2Sep 9, 2025
Tetrahydrobenzo-quinoline sulfonamides derivative compounds
UCB Biopharma SRL0 citations47
US12577228B2Mar 17, 2026
Dihydrocyclopenta-isoquinoline-sulfonamide derivatives compounds
UCB Biopharma SRL0 citations41
US10793578B2Oct 6, 2020
Fused pentacyclic imidazole derivatives as modulators of TNF activity
UCB Biopharma SRL0 citations39
US10766906B2Sep 8, 2020
Fused hexacyclic imidazole derivatives as modulators of TNF activity
UCB Biopharma SRL0 citations38
US10669286B2Jun 2, 2020
Fused pentacyclic imidazole derivatives as modulators of TNF activity
UCB Biopharma SRL0 citations38
US10654861B2May 19, 2020
Fused pentacyclic imidazole derivatives as modulators of TNF activity
UCB Biopharma SRL0 citations34
UCB BIOPHARMA SPRL
8 patentsUS9969728B2May 15, 2018
Tetrahydroimidazopyridine derivatives as modulators of TNF activity
UCB BIOPHARMA SPRL14 citations82
US10087179B2Oct 2, 2018
Fused tricyclic imidazole derivatives as modulators of TNF activity
UCB BIOPHARMA SPRL8 citations81
US9932343B2Apr 3, 2018
Fused tricyclic benzimidazoles derivatives as modulators of TNF activity
UCB BIOPHARMA SPRL10 citations81
US9890174B2Feb 13, 2018
Fused Tricyclic imidazole derivatives as modulators of TNF activity
UCB BIOPHARMA SPRL8 citations81
US9926313B2Mar 27, 2018
Imidazopyridine derivatives as modulators of TNF activity
UCB BIOPHARMA SPRL2 citations71
US10202405B2Feb 12, 2019
Fused pentacyclic imidazole derivatives
UCB BIOPHARMA SPRL4 citations70
US10472362B2Nov 12, 2019
Fused tricyclic imidazo pyrazines as modulators of TNF activity
UCB BIOPHARMA SPRL1 citations62
US10093652B2Oct 9, 2018
Tetrahydrobenzimidazole derivatives as modulators of TNF activity
UCB BIOPHARMA SPRL1 citations51
HEER JAG PAUL
4 patentsUS8278324B2Oct 2, 2012
Oxadiazole derivatives active on sphingosine-1-phosphate (S1P)
HEER JAG PAUL1 citations49
US8263620B2Sep 11, 2012
Oxadiazole derivatives active on sphingosine-1-phosphate (SIP)
HEER JAG PAUL0 citations49
US8093249B2Jan 10, 2012
Pyrazolo[1,5-A]pyrimidine-carbonyl-piperazine derivatives
HEER JAG PAUL0 citations48
US8697703B2Apr 15, 2014
Piperazine derivatives for blocking Cav2.2 calcium channels
HEER JAG PAUL0 citations39
BESWICK PAUL JOHN
3 patentsUS8288388B2Oct 16, 2012
3-pyridylcarbonyl-piperazinylsulfonyl derivatives
BESWICK PAUL JOHN4 citations57
US8536183B2Sep 17, 2013
3-pyridylcarbonyl-piperazinylsulfonyl derivatives
BESWICK PAUL JOHN0 citations47
US8530478B2Sep 10, 2013
Piperazine derivatives used as CAV2.2 calcium channel modulators
BESWICK PAUL JOHN0 citations47